PO.TB04.03 · 肿瘤生物学

结直肠癌细胞与癌相关成纤维细胞在不同促纤维增生反应亚型间的相互作用

Interactions between colorectal cancer cells and cancer-associated fibroblasts across desmoplastic reaction subtypes

海报缩略图:结直肠癌细胞与癌相关成纤维细胞在不同促纤维增生反应亚型间的相互作用
编号 4866 展板 15 时间 4/21 09:00–12:00 区域 Section 28 主讲 Wataru Kosaka, No Degree
分会场 In Vitro Models 2: 2D, 3D, Organoids, and Spheroids
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Wataru Kosaka1, Keigo Murakami2, Yota Akamori1, Hideaki Karasawa1, Yuki Yasuda1, Ichiro Ise1, Tomoyuki Ono1, Megumi Murakami1, Yoshihiro Sato1, Gumpei Yoshimatsu1, Hideyuki Suzuki1, Takashi Kamei1, Shinobu Ohnuma1, Toru Furukawa2, Michiaki Unno1

1Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan,2Department of Investigative Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan

摘要 Abstract

中文摘要
结直肠癌(CRC)浸润前沿的促纤维增生反应(DR)近来作为一项重要的预后指标以及反映肿瘤-间质相互作用的组织学特征而日益受到关注。根据间质形态,DR被分为成熟型、中间型和不成熟型,每种类型分别代表周围微环境的不同生物学状态。既往的临床病理研究表明,不成熟型和中间型DR与不良预后相关;然而,这些预后差异背后的生物学机制仍未得到充分理解。由于癌相关成纤维细胞(CAFs)构成了DR的主要间质成分,并对间质结构产生关键性影响,我们旨在通过结合一个特征明确的临床队列的分析与一个纳入患者来源CRC类器官和CAFs的三维共培养系统,来阐明CRC-CAF之间的相互作用。我们回顾性纳入了2013至2018年间在本机构接受CRC(pT3或更高)手术切除的269例连续患者。对临床病理和预后变量进行了详细分析,并重点分析了191例未接受术前治疗的II/III期患者,以减少治疗相关的混杂因素。在标准化培养条件下,从切除的肿瘤中建立了原代CRC类器官和CAFs,并通过组织学确定了每个CAF系所对应的DR亚型。为进一步探讨间质生物学,采用蛋白质组学分析来表征DR亚型特异性的蛋白表达特征,并研究与间质表型相关的分子特征。不成熟型DR与侵袭性临床病理特征显著相关,包括更高的T分期(T3 66.0%,T4 34.0%,P值:0.0011)和N分期(pN1-3 62.3%,P值:< 0.001)、血管侵犯(阳性98.1%,P值:< 0.001)以及其他肿瘤侵袭性指标,而成熟型DR则与更为有利的临床结局相关。在三维共培养实验中,CRC类器官与不成熟型CAFs配对时表现出最强的增殖扩增,凸显了间质不成熟性在促进肿瘤生长中的功能相关性(P值:< 0.05)。蛋白质组学分析揭示了各DR亚型之间的明显分离,反映了每种亚型特有的不同蛋白表达谱。值得注意的是,在不成熟型DR中,以整合素为核心的细胞黏附相关通路、肌动蛋白调控通路以及脂肪酸代谢通路位于富集程度最高的通路之列。这些发现支持将DR分类作为CRC具有临床意义的预后因素,并表明不成熟型CAFs在促进CRC细胞生长中发挥关键作用。
查看英文原文 English abstract
The desmoplastic reaction (DR) at the invasive front of colorectal cancer (CRC) has recently gained increasing attention as an important prognostic indicator and as a histological hallmark that reflects tumor-stroma interactions. DR is classified into mature, intermediate, and immature patterns based on stromal morphology, each representing distinct biological states of the surrounding microenvironment. Previous clinicopathological studies have demonstrated that immature and intermediate DR are associated with unfavorable outcomes; however, the biological mechanisms underlying these prognostic differences remain insufficiently understood. Because cancer-associated fibroblasts (CAFs) constitute the predominant stromal component of DR and critically influence stromal architecture, we aimed to clarify CRC-CAF interactions by combining analyses from a well-characterized clinical cohort and a three-dimensional co-culture system incorporating patient-derived CRC organoids and CAFs.We retrospectively identified 269 consecutive patients who underwent surgical resection for CRC (pT3 or higher) between 2013 and 2018 at our institution. Clinicopathological and prognostic variables were examined in detail, with a focused analysis of 191 stage II/III patients who did not receive preoperative therapy to reduce treatment-related confounding. Primary CRC organoids and CAFs were established from resected tumors under standardized culture conditions, and the DR subtype corresponding to each CAF line was determined histologically. To further explore stromal biology, proteomic profiling was performed to characterize DR subtype-specific protein expression signatures and to investigate molecular features associated with stromal phenotypes.Immature DR demonstrated significant associations with aggressive clinicopathological characteristics, including higher T (T3 66.0%, T4 34.0% P-value : 0.0011) and N (pN1-3 62.3% P-value : < 0,001) categories, vascular invasion (positive 98.1% P-value : < 0,001), and other indicators of tumor invasiveness, whereas mature DR was linked to more favorable clinical outcomes. In three-dimensional co-culture assays, CRC organoids exhibited the greatest proliferative expansion when paired with immature CAFs, emphasizing the functional relevance of stromal immaturity in promoting tumor growth (P-value : < 0.05). Proteomic analysis revealed clear segregation among DR subtypes, reflecting distinct protein expression profiles characteristic of each subtype. Notably, in immature DR, pathways related to cell adhesion centered on integrins, actin-regulation pathways, and fatty acid metabolism were among the top enriched pathways.These findings support DR classification as a clinically meaningful prognostic factor in CRC and indicate that immature CAFs play a key role in promoting CRC cell growth.
利益披露 Disclosure
W. Kosaka, None.. K. Murakami, None.. Y. Akamori, None.. H. Karasawa, None.. Y. Yasuda, None.. I. Ise, None.. T. Ono, None.. M. Murakami, None.. Y. Sato, None.. G. Yoshimatsu, None.. H. Suzuki, None.. T. Kamei, None.. S. Ohnuma, None.. T. Furukawa, None.. M. Unno, None.

← 返回 AACR 2026 检索